Herpes Simplex Virus Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Virus Type, By Treatment, By Route of Administration, By Distribution Channel, By Region
세계 단순포진바이러스 치료 시장은 예측 기간 동안 괄목할 만한 성장을 보일 것으로 예상됩니다. 이는 고령화 인구의 증가, 단순 포진 감염 및 HIV와 같은 질병의 사례 증가에 기인합니다. 또한, 신흥국의 비위생적인 습관의 사용 증가와 연구 개발 활동에 대한 투자 증가로 인해 전 세계 여러 지역에서 단순포진바이러스 치료에 대한 수요가 크게 증가하고 있습니다. 또한, 희귀 질환에 대한 효율적인 치료에 대한 수요가 증가함에 따라 단순포진바이러스 치료에 대한 수요가 더욱 증가하여 2028년까지 시장 성장을 촉진할 것으로 예상됩니다. 또한, 새로운 치료법 사용의 이점에 대한 인식이 높아짐에 따라 전 세계적으로 HSV 치료에 대한 의료비 지출이 증가함에 따라 예측 기간 동안 단순포진바이러스 치료 시장을 더욱 지원할 것으로 예상됩니다.
HSV 감염률 증가
단순포진바이러스 감염의 유병률 증가, 병원 내 감염률 증가, 신종 바이러스를 유발하는 미생물의 급속한 변이가 예측 기간 동안 시장 성장을 촉진하는 주요 요인으로 작용할 것으로 보입니다. 또한, 저개발 지역과 신흥국 시장의 전염병 전파 증가와 청결 부족은 예측 기간 동안 단순포진바이러스 치료 시장을 더욱 촉진하고 있습니다. 세계보건기구(WHO)에 따르면, HSV-2에 감염된 여성은 남성보다 더 많으며, 2012년에는 2억 6,700만 명의 여성과 1억 5,000만 명의 남성이 HSV-2에 감염된 것으로 추정되며, HSV 뇌염의 부담이 증가함에 따라 이 부문의 시장을 촉진할 것으로 예상됩니다. 미국 국립희귀질환연구소(National Organization for Rare Disorders)에 따르면, 미국 내 급성 뇌염의 유병률은 연간 약 2,000건으로 미국에서 발생하는 전체 뇌염 사례의 약 10%를 차지합니다. 또한, 약물 개발에 대한 관심 증가, 재택 의료 환경과 현장 진단의 높은 도입에 따른 정밀 의료에 대한 수요 증가, 연구 개발 활동에 대한 투자 증가는 예측 기간 동안 세계 시장의 성장을 촉진할 것으로 예상됩니다.
보건의료비 지출 증가
제약 및 헬스케어 부문은 기술 혁신, 헬스케어 지출 증가, 헬스케어 시설 및 시스템 개선으로 인해 빠르게 성장하고 있으며, 예측 기간 동안 유리한 성장세를 보일 것으로 예상됩니다. 많은 병원, 외래 수술 센터 및 클리닉이 전 세계적으로 첨단 장비와 장치를 도입하여 시장 성장을 촉진하고 있습니다. 연구 기관 간의 이니셔티브 개척과 공동 연구의 증가는 바이러스에 대한 새로운 치료법 개발을 촉진하고 있으며, 예측 기간 동안 시장 성장을 촉진할 것으로 예상됩니다. 2020년 1월 스위스 로잔의 EPFL, 제네바 대학교(UNIGE), 맨체스터 대학교의 과학자들이 공동으로 진행한 연구를 통해 단순포진(입술 포진 바이러스) 치료에 유망한 당으로 만든 새로운 항바이러스 물질인 빌리사이드가 개발됐습니다.
사용 가능한 커스터마이징
TechSci Research는 주어진 시장 데이터를 사용하여 기업의 특정 요구에 따라 맞춤화할 수 있습니다. 보고서에서 다음과 같은 커스터마이징이 가능합니다.
회사 소개
- 추가 시장 진입 기업(최대 5개사)에 대한 심층 분석 및 프로파일링
목차
제1장 개요
제2장 조사 방법
- 조사 목적
- 베이스라인 조사 방법
- 주요 산업 파트너
- 주요 협회와 2차 정보 출처
- 예측 방법
- 데이터 삼각측량과 검증
- 가정과 한계
제3장 주요 요약
- 시장 개요
- 주요 시장 세분화 개요
- 주요 시장 기업 개요
- 주요 지역/국가 개요
- 시장 성장 촉진요인, 과제, 동향 개요
제4장 고객의 소리
제5장 임상시험 분석
제6장 단순포진바이러스 치료 세계 시장 전망
- 시장 규모와 예측
- 시장 점유율과 예측
- 바이러스 유형별
- 치료법별
- 투여 경로별
- 유통 채널별
- 지역별
- 기업별
- 시장 맵
- 바이러스 유형별
- 치료제별
- 투여 경로별
- 유통 채널별
제7장 북미의 단순포진바이러스 치료 시장 전망
- 시장 규모와 예측
- 시장 점유율과 예측
- 바이러스 유형별(HSV-1 vs HSV-2)
- 치료제별(약 vs 백신)
- 투여 경로별(경구제, 점적제, 국소제)
- 유통 채널별(병원 약국, 소매 약국, 온라인 약국)
- 국가별
- 북미 국가별 분석
제8장 유럽의 단순포진바이러스 치료 시장 전망
- 시장 규모와 예측
- 시장 점유율과 예측
- 바이러스 유형별(HSV-1 vs HSV-2)
- 치료제별(약 vs 백신)
- 투여 경로별(경구제, 점적제, 국소제)
- 유통 채널별(병원 약국, 소매 약국, 온라인 약국)
- 국가별
- 유럽 국가별 분석
제9장 아시아태평양의 단순포진바이러스 치료 시장 전망
- 시장 규모와 예측
- 시장 점유율과 예측
- 바이러스 유형별(HSV-1 vs HSV-2)
- 치료제별(약 vs 백신)
- 투여 경로별(경구제, 점적제, 국소제)
- 유통 채널별(병원 약국, 소매 약국, 온라인 약국)
- 국가별
- 아시아태평양 국가별 분석
제10장 남미의 단순포진바이러스 치료 시장 전망
- 시장 규모 및 예측
- 시장 점유율과 예측
- 바이러스 유형별(HSV-1 vs HSV-2)
- 치료제별(약 vs 백신)
- 투여 경로별(경구제, 점적제, 국소제)
- 유통 채널별(병원 약국, 소매 약국, 온라인 약국)
- 국가별
- 남미 : 국가별 분석
제11장 중동 및 아프리카의 단순포진바이러스 치료 시장 전망
- 시장 규모 및 예측
- 시장 점유율과 예측
- 바이러스 유형별(HSV-1 vs HSV-2)
- 치료제별(약 vs 백신)
- 투여 경로별(경구제, 점적제, 국소제)
- 유통 채널별(병원 약국, 소매 약국, 온라인 약국)
- 국가별
- MEA : 국가별 분석
제12장 시장 역학
제13장 시장 동향과 발전
제14장 경쟁 상황
- Business Overview
- Company Snapshot
- Products & Services
- Financials(As reported)
- Recent Developments
- SWOT Analysis
- Novartis International AG
- GlaxoSmithKline, plc.
- Sanofi SA
- Mylan N.V.
- Emcure Pharmaceuticals Ltd.
- Glenmark Pharmaceuticals Inc.
- Fresenius Kabi AG
- Apotex Inc.
- Viatris Inc.
- Teva Pharmaceuticals Industries Ltd
제15장 전략적 제안
ksm
Global Herpes Simplex Virus (HSV) Treatment Market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the growing aging population and increased cases of diseases like Herpes Simplex infection and HIV. Additionally, the growing usage of unhygienic practices in emerging countries, along with rising investments in research and development activities, have significantly increased the demand for herpes simplex virus treatment across different parts of the globe. Moreover, the growing demand for efficient treatment for rare conditions is further expected to increase the demand for herpes simplex virus treatment, thereby fuelling market growth through 2028. Besides, growing awareness about the advantages of using new treatments, along with increasing healthcare expenditure on HSV treatment across the globe, is further expected to support the herpes simplex virus treatment market during the forecast period.
Increasing prevalence of HSV Infection
The increasing prevalence of Herpes Simplex Virus infection, along with the increasing rate of hospital-acquired infection and rapid mutations in the microorganism leading to new strains, are the major factors that will drive the growth of the market during the forecast period. Furthermore, the increasing transmission of infectious disease and lack of cleanliness in underdeveloped and developing regions are further propelling the herpes simplex virus infection treatment market during the forecast period. According to the World Health Organization, more women are infected with HSV-2 than men. In 2012, an estimated 267 million women and 150 million men were living with the infection. The rising burden of HSV encephalitis is expected to propel the market in this segment. As per the National Organization for Rare Disorders, the prevalence of acute encephalitis in the U.S. is around 2,000 cases per year, and it includes around 10% of total cases of encephalitis occurring in the U.S. Additionally, the rising focus on drug development, increasing demand for precision medicine along with high adoption of home care settings and point-of-care diagnostics, growing investments in research and development activities are expected to drive global market growth during the forecast period.
Growing Healthcare Expenditure
The pharma and healthcare sector are rapidly growing with technological innovations, increasing healthcare spending, and improving healthcare facilities and systems, which is expected to create lucrative growth during the forecast period. Many hospitals, ambulatory surgical care centers, and clinics are adopting advanced devices and equipment across the globe, which will enhance the growth of the market. Increasing initiatives and increasing collaborations between research organizations are facilitating the development of novel treatment alternatives against viruses, which is expected to boost market growth during the forecast period. In January 2020, a research collaboration between scientists from the EPFL in Lausanne, Switzerland, the University of Geneva (UNIGE), and the University of Manchester led to the development of novel antiviral materials, virucides, made from sugar that show promise for the treatment of herpes simplex (cold sore virus).
Market Segmentation
The global Herpes Simplex Virus (HSV) Treatment Market can be segmented by virus type, treatment, route of administration, distribution channel, and by region. Based on the virus type, the market can be divided into HSV-1 v/s HSV-2. Based on treatment, the market can be divided into Drugs v/s Vaccines. Based on the route of administration, the market can be differentiated into Oral, Intravenous, and Topical. Based on distribution channel, the market can be segmented into Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, the United States dominated the global herpes simplex virus treatment market on account of the growing demand for treatments due to the increasing prevalence of herpes simplex virus infection.
Market Players
Novartis International AG, GlaxoSmithKline, plc., Sanofi SA, Mylan N.V., Emcure Pharmaceuticals Ltd., Glenmark Pharmaceuticals Inc., Fresenius Kabi AG, Apotex Inc., Viatris Inc., Teva Pharmaceuticals Industries Ltd are some of the leading players operating in the Global Herpes Simplex Virus (HSV) Treatment Market.
Report Scope
In this report, Global Herpes Simplex Virus (HSV) Treatment systems market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:
Herpes Simplex Virus (HSV) Treatment Market, By Virus Type:
Herpes Simplex Virus (HSV) Treatment Market, By Treatment:
- Drugs
- Acyclovir
- Valacyclovir
- Famciclovir
- Others
Herpes Simplex Virus (HSV) Treatment Market, By Route of Administration:
Herpes Simplex Virus (HSV) Treatment Market, By Distribution Channel:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Herpes Simplex Virus (HSV) Treatment Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- Germany
- United Kingdom
- Italy
- Spain
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in Global Herpes Simplex Virus (HSV) Treatment Market.
Available Customizations
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
- 1.1. Market Definition
- 1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations
2. Research Methodology
- 2.1. Objective of the Study
- 2.2. Baseline Methodology
- 2.3. Key Industry Partners
- 2.4. Major Association and Secondary Sources
- 2.5. Forecasting Methodology
- 2.6. Data Triangulation & Validation
- 2.7. Assumptions and Limitations
3. Executive Summary
- 3.1. Overview of the Market
- 3.2. Overview of Key Market Segmentations
- 3.3. Overview of Key Market Players
- 3.4. Overview of Key Regions/Countries
- 3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Clinical Trial Analysis
- 5.1. Ongoing Clinical Trials
- 5.2. Completed Clinical Trials
- 5.3. Terminated Clinical Trials
- 5.4. Breakdown of Pipeline, By Development Phase
- 5.5. Breakdown of Pipeline, By Status
- 5.6. Breakdown of Pipeline, By Study Application
- 5.7. Breakdown of Pipeline, By Region
- 5.8. Clinical Trials Heat Map
6. Global Herpes Simplex Virus (HSV) Treatment Market Outlook
- 6.1. Market Size & Forecast
- 6.2. Market Share & Forecast
- 6.2.1. By Virus Type (HSV-1 v/s HSV-2)
- 6.2.2. By Treatment (Drugs v/s Vaccines)
- 6.2.2.1. By Drugs (Acyclovir, Valacyclovir, Famciclovir, Others)
- 6.2.2.2. By Vaccines (Simplirix, Others)
- 6.2.3. By Route of Administration (Oral, Intravenous, Topical)
- 6.2.4. By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)
- 6.2.5. By Region
- 6.2.6. By Company (2022)
- 6.3. Market Map
- 6.3.1. By Virus Type
- 6.3.2. By Treatment
- 6.3.3. By Route of Administration
- 6.3.4. By Distribution Channel
7. North America Herpes Simplex Virus (HSV) Treatment Market Outlook
- 7.1. Market Size & Forecast
- 7.2. Market Share & Forecast
- 7.2.1. By Virus Type (HSV-1 v/s HSV-2)
- 7.2.2. By Treatment (Drugs v/s Vaccines)
- 7.2.2.1. By Drugs (Acyclovir, Valacyclovir, Famciclovir, Others)
- 7.2.2.2. By Vaccines (Simplirix, Others)
- 7.2.3. By Route of Administration (Oral, Intravenous, Topical)
- 7.2.4. By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)
- 7.2.5. By Country
- 7.3. North America: Country Analysis
- 7.3.1. United States Herpes Simplex Virus (HSV) Treatment Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Virus Type
- 7.3.1.2.2. By Treatment
- 7.3.1.2.3. By Route of Administration
- 7.3.1.2.4. By Distribution Channel
- 7.3.2. Canada Herpes Simplex Virus (HSV) Treatment Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Virus Type
- 7.3.2.2.2. By Treatment
- 7.3.2.2.3. By Route of Administration
- 7.3.2.2.4. By Distribution Channel
- 7.3.3. Mexico Herpes Simplex Virus (HSV) Treatment Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Virus Type
- 7.3.3.2.2. By Treatment
- 7.3.3.2.3. By Route of Administration
- 7.3.3.2.4. By Distribution Channel
8. Europe Herpes Simplex Virus (HSV) Treatment Market Outlook
- 8.1. Market Size & Forecast
- 8.2. Market Share & Forecast
- 8.2.1. By Virus Type (HSV-1 v/s HSV-2)
- 8.2.2. By Treatment (Drugs v/s Vaccines)
- 8.2.2.1. By Drugs (Acyclovir, Valacyclovir, Famciclovir, Others)
- 8.2.2.2. By Vaccines (Simplirix, Others)
- 8.2.3. By Route of Administration (Oral, Intravenous, Topical)
- 8.2.4. By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)
- 8.2.5. By Country
- 8.3. Europe: Country Analysis
- 8.3.1. France Herpes Simplex Virus (HSV) Treatment Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Virus Type
- 8.3.1.2.2. By Treatment
- 8.3.1.2.3. By Route of Administration
- 8.3.1.2.4. By Distribution Channel
- 8.3.2. Germany Herpes Simplex Virus (HSV) Treatment Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Virus Type
- 8.3.2.2.2. By Treatment
- 8.3.2.2.3. By Route of Administration
- 8.3.2.2.4. By Distribution Channel
- 8.3.3. United Kingdom Herpes Simplex Virus (HSV) Treatment Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Virus Type
- 8.3.3.2.2. By Treatment
- 8.3.3.2.3. By Route of Administration
- 8.3.3.2.4. By Distribution Channel
- 8.3.4. Italy Herpes Simplex Virus (HSV) Treatment Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Virus Type
- 8.3.4.2.2. By Treatment
- 8.3.4.2.3. By Route of Administration
- 8.3.4.2.4. By Distribution Channel
- 8.3.5. Spain Herpes Simplex Virus (HSV) Treatment Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Virus Type
- 8.3.5.2.2. By Treatment
- 8.3.5.2.3. By Route of Administration
- 8.3.5.2.4. By Distribution Channel
9. Asia-Pacific Herpes Simplex Virus (HSV) Treatment Market Outlook
- 9.1. Market Size & Forecast
- 9.2. Market Share & Forecast
- 9.2.1. By Virus Type (HSV-1 v/s HSV-2)
- 9.2.2. By Treatment (Drugs v/s Vaccines)
- 9.2.2.1. By Drugs (Acyclovir, Valacyclovir, Famciclovir, Others)
- 9.2.2.2. By Vaccines (Simplirix, Others)
- 9.2.3. By Route of Administration (Oral, Intravenous, Topical)
- 9.2.4. By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)
- 9.2.5. By Country
- 9.3. Asia-Pacific: Country Analysis
- 9.3.1. China Herpes Simplex Virus (HSV) Treatment Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Virus Type
- 9.3.1.2.2. By Treatment
- 9.3.1.2.3. By Route of Administration
- 9.3.1.2.4. By Distribution Channel
- 9.3.2. India Herpes Simplex Virus (HSV) Treatment Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Virus Type
- 9.3.2.2.2. By Treatment
- 9.3.2.2.3. By Route of Administration
- 9.3.2.2.4. By Distribution Channel
- 9.3.3. Japan Herpes Simplex Virus (HSV) Treatment Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Virus Type
- 9.3.3.2.2. By Treatment
- 9.3.3.2.3. By Route of Administration
- 9.3.3.2.4. By Distribution Channel
- 9.3.4. South Korea Herpes Simplex Virus (HSV) Treatment Market Outlook
- 9.3.4.1. Market Size & Forecast
- 9.3.4.2. Market Share & Forecast
- 9.3.4.2.1. By Virus Type
- 9.3.4.2.2. By Treatment
- 9.3.4.2.3. By Route of Administration
- 9.3.4.2.4. By Distribution Channel
- 9.3.5. Australia Herpes Simplex Virus (HSV) Treatment Market Outlook
- 9.3.5.1. Market Size & Forecast
- 9.3.5.2. Market Share & Forecast
- 9.3.5.2.1. By Virus Type
- 9.3.5.2.2. By Treatment
- 9.3.5.2.3. By Route of Administration
- 9.3.5.2.4. By Distribution Channel
10. South America Herpes Simplex Virus (HSV) Treatment Market Outlook
- 10.1. Market Size & Forecast
- 10.2. Market Share & Forecast
- 10.2.1. By Virus Type (HSV-1 v/s HSV-2)
- 10.2.2. By Treatment (Drugs v/s Vaccines)
- 10.2.2.1. By Drugs (Acyclovir, Valacyclovir, Famciclovir, Others)
- 10.2.2.2. By Vaccines (Simplirix, Others)
- 10.2.3. By Route of Administration (Oral, Intravenous, Topical)
- 10.2.4. By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)
- 10.2.5. By Country
- 10.3. South America: Country Analysis
- 10.3.1. Brazil Herpes Simplex Virus (HSV) Treatment Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Virus Type
- 10.3.1.2.2. By Treatment
- 10.3.1.2.3. By Route of Administration
- 10.3.1.2.4. By Distribution Channel
- 10.3.2. Argentina Herpes Simplex Virus (HSV) Treatment Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Virus Type
- 10.3.2.2.2. By Treatment
- 10.3.2.2.3. By Route of Administration
- 10.3.2.2.4. By Distribution Channel
- 10.3.3. Colombia Herpes Simplex Virus (HSV) Treatment Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Virus Type
- 10.3.3.2.2. By Treatment
- 10.3.3.2.3. By Route of Administration
- 10.3.3.2.4. By Distribution Channel
11. Middle East and Africa Herpes Simplex Virus (HSV) Treatment Market Outlook
- 11.1. Market Size & Forecast
- 11.2. Market Share & Forecast
- 11.2.1. By Virus Type (HSV-1 v/s HSV-2)
- 11.2.2. By Treatment (Drugs v/s Vaccines)
- 11.2.2.1. By Drugs (Acyclovir, Valacyclovir, Famciclovir, Others)
- 11.2.2.2. By Vaccines (Simplirix, Others)
- 11.2.3. By Route of Administration (Oral, Intravenous, Topical)
- 11.2.4. By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)
- 11.2.5. By Country
- 11.3. MEA: Country Analysis
- 11.3.1. South Africa Herpes Simplex Virus (HSV) Treatment Market Outlook
- 11.3.1.1. Market Size & Forecast
- 11.3.1.2. Market Share & Forecast
- 11.3.1.2.1. By Virus Type
- 11.3.1.2.2. By Treatment
- 11.3.1.2.3. By Route of Administration
- 11.3.1.2.4. By Distribution Channel
- 11.3.2. Saudi Arabia Herpes Simplex Virus (HSV) Treatment Market Outlook
- 11.3.2.1. Market Size & Forecast
- 11.3.2.2. Market Share & Forecast
- 11.3.2.2.1. By Virus Type
- 11.3.2.2.2. By Treatment
- 11.3.2.2.3. By Route of Administration
- 11.3.2.2.4. By Distribution Channel
- 11.3.3. UAE Herpes Simplex Virus (HSV) Treatment Market Outlook
- 11.3.3.1. Market Size & Forecast
- 11.3.3.2. Market Share & Forecast
- 11.3.3.2.1. By Virus Type
- 11.3.3.2.2. By Treatment
- 11.3.3.2.3. By Route of Administration
- 11.3.3.2.4. By Distribution Channel
12. Market Dynamics
- 12.1. Drivers
- 12.2. Challenges
13. Market Trends & Developments
- 13.1. Recent Developments
- 13.2. Mergers & Acquisitions
- 13.3. Product Launches
14. Competitive Landscape
- 14.1. Business Overview
- 14.2. Company Snapshot
- 14.3. Products & Services
- 14.4. Financials (As reported)
- 14.5. Recent Developments
- 14.6. SWOT Analysis
- 14.6.1. Novartis International AG
- 14.6.2. GlaxoSmithKline, plc.
- 14.6.3. Sanofi SA
- 14.6.4. Mylan N.V.
- 14.6.5. Emcure Pharmaceuticals Ltd.
- 14.6.6. Glenmark Pharmaceuticals Inc.
- 14.6.7. Fresenius Kabi AG
- 14.6.8. Apotex Inc.
- 14.6.9. Viatris Inc.
- 14.6.10. Teva Pharmaceuticals Industries Ltd
15. Strategic Recommendations
